Skip to main content
Equibles
RGA logo

RGA · Reinsurance Group Of America Inc

Track RGA — free

Use RGA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RGA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$249.45 -0.93 (-0.37%) At close · Aug 14
Market Cap
$16.29B
Shares
65.30M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$249.45 Open$250.25 Day$242.18–251.00 52W close$181.54–250.38 Avg vol 30d365K Short int801K · 1.2% float · 2.3d Short vol49% Last earningsAug 7, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 7

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 7, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Strong Buy
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very Low
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +19%
      above
      Price vs 50-day avg +10%
      above
      RSI (14) 68
      neutral
      MACD trend Positive
      52-week position 99%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +3%
      trailing
      6-month return +15%
      trailing
      YTD return +23%
      this year
      Relative strength +1%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $227 › 200d $209 — 50d above 200d
      Institutional flow Distributing
      -0% holders QoQ · +67 funds added
      Insider flow Distributing
      Net -$89.0K over 90 days · 100% sells
      Short interest Falling
      1.23% of float · ▼ -27.2% MoM · 2.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      617 holders — mid 3-yr range
      Squeeze score 41
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +7%
      Y/Y
      EPS growth +65%
      Y/Y
      Free cash flow $4.1B
      Buyback $400.0M
      remaining
      Balance sheet $1.5B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 23%
      annualized · 1-yr
      Max drawdown −13%
      past year
      ATR 2.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Dec 31, 2025
      Effective tax rate · 2026 22% – 23%
      Prior guidance period ended · from the Earnings Call filed Jun 30, 2024
      Effective tax rate · full year 24% – 25%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +19% Bullish
      Price vs 50-day avg
      +10% Bullish
      RSI (14)
      68 Neutral
      MACD trend
      Positive Bullish
      52-week position
      99% Bullish
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $227 › 200d $209 — 50d above 200d
      Institutional flow Distributing
      -0% holders QoQ · +67 funds added
      Insider flow Distributing
      Net -$89.0K over 90 days · 100% sells
      Short interest Falling
      1.23% of float · ▼ -27.2% MoM · 2.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      617 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $182 Now $249 · 99% Range high $250
      vs 200-day avg +19% vs 50-day avg +10%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted operating income non-GAAP $1.87B Trailing Twelve Months Ended June 30, 2026 —
      Adjusted operating income per diluted share non-GAAP $8.89 Q2 FY2026 —
      Adjusted operating income, excluding notable items non-GAAP $1.99B Trailing Twelve Months Ended June 30, 2026 —
      Adjusted operating income, excluding notable items per diluted share non-GAAP $8.89 Q2 FY2026 —
      Adjusted operating return on equity (excluding AOCI and notable items) non-GAAP 18.4% Three Months Ended June 30, 2026 —
      Adjusted operating return on equity (excluding AOCI) non-GAAP 17.4% Three Months Ended June 30, 2026 —
      Adjusted operating return on equity (excluding AOCI, B36, and notable items) non-GAAP 18.3% Three Months Ended June 30, 2026 —
      Annualized investment yield 5.13% Six months ended June 30, 2026 —
      Annualized investment yield excluding VII 4.9% Six months ended June 30, 2026 —
      Assumed Life Reinsurance In Force $1.93T Q2 2026 —
      Book value per share, excluding accumulated other comprehensive income (AOCI) non-GAAP $173.77 Q2 FY2026 —
      Book value per share, excluding AOCI and B36 non-GAAP $174.11 Q2 FY2026 —
      Capital returned to shareholders $111M Q2 FY2026 —
      Creditor reinsurance net premiums non-GAAP $16M June 30, 2026 —
      Critical illness net premiums $867M Six months ended June 30, 2026 —
      Dividends paid $61M Q2 FY2026 —
      Net interest spread non-GAAP 1.2% June 30, 2026 —
      Shares repurchased $50M Q2 FY2026 —
      Adjusted operating ROE non-GAAP 15.2% trailing twelve months —
      Adjusted operating ROE, excluding notable items non-GAAP 16.2% trailing twelve months —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Insurance - Reinsurance — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RGA
      Reinsurance Group Of America Inc
      this stock
      		$16.29B +22.6% +7.2% 11.0 1.2%
      EG
      Everest Group, Ltd.
      		 $14.19B +9.1% +1.2% 7.8 4.1%
      RNR
      Renaissancere Holdings Ltd
      		 $13.44B +15.0% +9.9% — 3.0%
      SPNT
      SiriusPoint Ltd
      		 $2.66B +8.4% +23.1% 5.7 4.0%
      HG
      Hamilton Insurance Group, Ltd.
      		 $2.36B +28.1% +24.7% — 2.6%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      617
      % held
      99.2%
      Net QoQ
      +620.9K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      558
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      800.5K
      Days to cover
      2.3d
      Change
      -299.5K sh
      View
      Short Volume
      Short vol %
      49%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      13
      Value
      $3.0K
      As of
      Jul 9, 2026
      View
      Off-Exchange
      Off-exchange %
      39.7%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$89.0K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      John James
      Amount
      $1.0K–$15.0K
      Traded
      Sep 4, 2024
      View
      Financials
      Financials
      Revenue (FY)
      $23.7B
      Net income (FY)
      $1.2B
      EPS diluted
      $17.69
      View
      Buybacks
      Authorized
      $500.0M
      Remaining
      $400.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 7, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $2.1M
      Shares
      8.6K
      Filed
      Aug 12, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 7, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      RGA +1.3% +3.2% +15.2% +5.3% +22.6%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +0.9% -1.3% +1.4% +1.4% +8.8%

      Capital returns

      Latest dividend
      $0.93 / share · ex May 19, 2026
      Declared · upcoming
      $0.98 / share · ex Aug 18, 2026
      Raised 4.5%
      Paid (TTM)
      $2.79 / share · 3 payouts
      Dividend yield (TTM, derived)
      1.12%
      Buyback program · as of Jun 30, 2026
      Authorized
      $500.00M
      Spent (derived)
      $100.00M
      Remaining
      $400.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 898174 CUSIP 759351604 13F (30d) 602 filings 567 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)